PHASE I TRIAL OF CARBOPLATIN, BEVACIZUMAB, AND TEMSIROLIMUS IN ADVANCED SOLID TUMORS

被引:0
|
作者
Westin, S. [1 ]
Castaneda, M. [2 ]
Pal, N. [1 ]
Urbauer, D. [3 ]
Janku, F. [2 ]
Wheler, J. [2 ]
Piha-Paul, S. [2 ]
Naing, A. [2 ]
Tsimberidou, A. [2 ]
Fu, S. [2 ]
Hong, D. [2 ]
Subbiah, V. [2 ]
Zinner, R. [2 ]
Karp, D. [2 ]
Coleman, R. [2 ]
Moulder, S. [2 ]
Kurzrock, R. [4 ]
机构
[1] UT MD Anderson Canc Ctr, Gynecol Oncol & Reprod Med, Houston, TX USA
[2] UT MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX USA
[3] UT MD Anderson Canc Ctr, Biostat, Houston, TX USA
[4] Univ Calif San Diego, Hematol & Oncol, Houston, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ESGO-0717
引用
收藏
页码:365 / 365
页数:1
相关论文
共 50 条
  • [1] Phase I trial of sorafenib, bevacizumab, and temsirolimus in advanced solid tumors.
    Westin, Shannon Neville
    Smart, Melody L.
    Pal, Navdeep
    Urbauer, Diana L.
    Janku, Filip
    Wheler, Jennifer J.
    Piha-Paul, Sarina Anne
    Naing, Aung
    Tsimberidou, Apostolia Maria
    Fu, Siqing
    Falchook, Gerald Steven
    Hong, David S.
    Zinner, Ralph
    Subbiah, Vivek
    Culotta, Kirk Salvatore
    Lu, Karen H.
    Coleman, Robert L.
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors
    Nelson, Blessie Elizabeth
    Tsimberidou, Apostolia M.
    Fu, Xueyao
    Fu, Siqing
    Subbiah, Vivek
    Sood, Anil K.
    Rodon, Jordi
    Karp, Daniel D.
    Blumenschein, George
    Kopetz, Scott
    Pant, Shubham
    Piha-Paul, Sarina A.
    ONCOLOGIST, 2023, : e1100 - e1292
  • [3] Phase I trial of paclitaxel, bevacizumab, and temsirolimus in advanced solid malignancies.
    Westin, Shannon Neville
    Stashi, Erin
    Pal, Navdeep
    Urbauer, Diana L.
    Janku, Filip
    Piha-Paul, Sarina Anne
    Naing, Aung
    Tsimberidou, Apostolia Maria
    Fu, Siqing
    Hong, David S.
    Subbiah, Vivek
    Karp, Daniel D.
    Coleman, Robert L.
    Meric-Bernstam, Funda
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors
    Caroline I. Piatek
    Grace L. Raja
    Lingyun Ji
    Barbara Jennifer Gitlitz
    Tanya B. Dorff
    David I. Quinn
    James Hu
    Anthony B. El-Khoueiry
    Huyen Q. Pham
    Lynda Roman
    Agustin A. Garcia
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1227 - 1234
  • [5] Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors
    Piatek, Caroline I.
    Raja, Grace L.
    Ji, Lingyun
    Gitlitz, Barbara Jennifer
    Dorff, Tanya B.
    Quinn, David I.
    Hu, James
    El-Khoueiry, Anthony B.
    Pham, Huyen Q.
    Roman, Lynda
    Garcia, Agustin A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1227 - 1234
  • [6] Sunitinib and bevacizumab in advanced solid tumors: A phase I trial
    Cooney, M. M.
    Garcia, J. A.
    Elson, P.
    Mekhail, T.
    Dreicer, R.
    Nock, C. J.
    Bokar, J. A.
    Tyler, A.
    Beatty, K.
    Bukowski, R. M.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase I clinical trial of temsirolimus (T) and vinorelbine (V) in advanced solid tumors
    Lee, Grace Lauren
    Ji, Lingyun
    Gitlitz, Barbara Jennifer
    Dorff, Tanya B.
    Iqbal, Syma
    El-Khoueiry, Anthony B.
    Roman, Lynda
    Edwards, Susan
    Menendez, Xiomara
    Cheng, Phillip
    Quinn, David I.
    Cole, Sarah
    Garcia, Agustin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Phase I trial of carboplatin, irinotecan and etoposide in advanced solid tumors.
    Chiappori, A
    Simon, GR
    Kvols, L
    Tetteh, L
    Mahany, JJ
    Lush, R
    Sullivan, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 160S - 160S
  • [9] Gemcitabine and carboplatin combination in advanced solid tumors: A phase I trial.
    Tassinari, D
    Pasini, G
    Arcangeli, V
    Panzini, I
    Drudi, G
    Gianni, L
    Oliverio, G
    Sartori, S
    Fochessati, F
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141